Cargando…
Attenuation of opioid tolerance by ET(B) receptor agonist, IRL-1620, is independent of an accompanied decrease in nerve growth factor in mice
AIM: ET(A) receptor antagonists reverse opioid tolerance but the involvement of ET(B) receptors is unknown. In morphine or oxycodone tolerant mice we investigated (1) the effect of ET(B) receptor agonist, IRL-1620, on analgesic tolerance; (2) changes in expression of the brain ET(A) and ET(B) recept...
Autores principales: | Gulati, Shruti, Briyal, Seema, Jones, Shantel, Bhalla, Shaifali, Gulati, Anil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466593/ https://www.ncbi.nlm.nih.gov/pubmed/28626808 http://dx.doi.org/10.1016/j.heliyon.2017.e00317 |
Ejemplares similares
-
Anti-apoptotic activity of ET(B) receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia
por: Briyal, Seema, et al.
Publicado: (2019) -
Sovateltide (IRL-1620) activates neuronal differentiation and prevents mitochondrial dysfunction in adult mammalian brains following stroke
por: Ranjan, Amaresh K., et al.
Publicado: (2020) -
Author Correction: Anti-apoptotic activity of ET(B) receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia
por: Briyal, Seema, et al.
Publicado: (2020) -
Neuroprotective Effect of IRL-1620, an Endothelin B Receptor Agonist, on a Pediatric Rat Model of Middle Cerebral Artery Occlusion
por: Cifuentes, Enrique G., et al.
Publicado: (2018) -
Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke
por: Gulati, Anil, et al.
Publicado: (2021)